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 2 
Abstract 1 
To improve the sensitivity in chiral analysis by capillary electrophoresis without loss of 2 
optical resolution, application of large-volume sample stacking with an electroosmotic 3 
flow pump (LVSEP) was investigated. Effects of the addition of cyclodextrin (CD) into 4 
a running solution on the LVSEP preconcentration was theoretically studied, where the 5 
preconcentration efficiency and effective separation length would be slightly increased 6 
if the effective electrophoretic velocity (vep,eff,BGS) of the analytes was decreased by 7 
interacting with CD. In LVSEP-CD-modified capillary zone electrophoresis (CDCZE) 8 
and LVSEP-CD electrokinetic chromatography with reduced vep,eff,BGS, up to 1,000-fold 9 
sensitivity increases were achieved with almost no loss of resolution. In 10 
LVSEP-CD-modified micellar electrokinetic chromatography of amino acids with 11 
increased vep,eff,BGS, a 1,300-fold sensitivity increase was achieved without much loss of 12 
resolution, indicating the versatile applicability of LVSEP to many separation modes. 13 
An enantio-excess (EE) assay was also carried out in LVSEP-CDCZE, resulting in 14 
successful analyses of up to 99.6% EE. Finally, we analyzed ibuprofen in urine by 15 
desalting with a C18 solid-phase extraction column. As a typical result, 250 ppb 16 
ibuprofen was well concentrated and optically resolved with 84.0–86.6% recovery in 17 
LVSEP-CDCZE, indicating the applicability of LVSEP to real samples containing a 18 
large amount of unnecessary background salts. 19 
 3 
Introduction 1 
 Chiral compounds are recognized to play important roles in chemistry, biology, 2 
medicine, and pharmacology [1–3], so that the analytical methods for the chiral 3 
compounds require the high sensitivity, high optical resolution, and short analysis time. 4 
Among several chiral separation methods, such as high-performance liquid 5 
chromatography (HPLC), gas chromatography, and capillary electrophoresis (CE), CE 6 
exhibits high resolution with little sample consumption in a short analysis time. Several 7 
separation modes have been developed for chiral separation in CE, including micellar 8 
electrokinetic chromatography (MEKC), cyclodextrin (CD)-modified capillary zone 9 
electrophoresis (CDCZE), CD electrokinetic chromatography (CDEKC), CD-modified 10 
MEKC (CDMEKC), affinity capillary electrophoresis (ACE), and nonaqueous CE 11 
(NACE) [4–6]. However, the concentration sensitivity is quite poor because of the short 12 
optical path length and the small injection volume of sample solution.  13 
 To overcome such the drawback of CE, several online sample preconcentration 14 
techniques have been developed [7–21]. Although up to 1,000-fold sensitivity increases 15 
have been achieved in chiral analysis [7–16], optimization of the preconcentration 16 
conditions is usually required because the resolution was reduced due to the decrease in 17 
the effective separation length accompanying the increase in the sample injection 18 
volume [17–19]. Since the enantioseparation is not so easy without the optimal 19 
electrolyte composition, additional optimization of the preconcentration condition is one 20 
of the most serious disadvantages. Moreover, highly efficient preconcentration 21 
techniques often require multi-step procedures [16,20], which are quite bothersome and 22 
often cause the reduction in the analytical reproducibility. Hence, we focused on an 23 
online sample preconcentration technique using field amplified sample stacking, 24 
 4 
large-volume sample stacking with an electroosmotic flow (EOF) pump (LVSEP) 1 
[21–23], which provides the high sensitivity with almost no loss of resolution in a 2 
simple experimental procedure. In our previous work [22], up to 780-fold sensitivity 3 
increases were achieved with good separation performance in the CE analysis of 4 
oligosaccharides. Moreover, we did not need to optimize the sample injection volume, 5 
because the sample filled in the whole capillary could be concentrated. Thus, the 6 
application of LVSEP to the chiral analysis in CE is expected to improve the sensitivity 7 
with high enantioseparation efficiency and to minimize the optimization procedure of 8 
the experimental conditions and the multi-step preconcentration procedure. 9 
 In spite of the high preconcentration and separation ability of LVSEP, there has 10 
been no report on the separation performance in combining LVSEP with any separation 11 
modes except for the most basic separation mode, capillary zone electrophoresis (CZE). 12 
In LVSEP, the separation performance is determined by the inversion position of the 13 
sample migration where the EOF velocity and electrophoretic velocity of the analyte in 14 
a background solution (BGS) is balanced [23]. Hence, the change in the effective 15 
electrophoretic mobility in the different separation mode can cause the increase or 16 
decrease in the resolution. It is important to consider the effect of the separation mode 17 
on the resolution both theoretically and experimentally. 18 
 Our aims in this study are to clarify the effects of the separation mode on the 19 
resolution in LVSEP and to achieve the efficient improvement of the concentration 20 
sensitivity without loss of optical resolution and without complicated experimental 21 
procedures including the optimization steps. Theoretical investigation on the resolution 22 
in the LVSEP-applied chiral analysis using CDs as chiral selectors was performed by 23 
estimating the inversion position, which is expected to directly affect the effective 24 
 5 
separation length. Three enantioseparation modes, CDCZE, CDEKC, and CDMEKC, 1 
were carried out to evaluate the performance of the sensitivity improvement and the 2 
enantioseparation. An enantio-excess (EE) assay was also carried out in 3 
LVSEP-CDCZE. Finally, we performed the analysis of a drug component dissolved in a 4 
urine matrix to show how to analyze real samples containing a large amount of 5 
unnecessary background salts. The purification using a C18 solid-phase extraction 6 
(SPE) column was applied for the LVSEP analysis of the urine sample. 7 
 8 
 9 
Experimental Section 10 
Materials and Chemicals. 11 
 A fused silica capillary was purchased from Polymicro Technologies (Phoenix, AZ, 12 
USA), poly(vinyl alcohol) (PVA, Mw = 88,000, 99% hydrolyzed) was obtained from 13 
Japan Vam and Poval (Osaka, Japan), warfarin was purchased from Dr. Ehrenstorfer 14 
GmbH (Augsburg, Germany), thiourea, (±)-abscisic acid, racemic ibuprofen, 15 
(S)-(+)-2-(4-isobutylphenyl)propionic acid ((S)-ibuprofen), 16 
2,6-di-O-methyl-β-cyclodextrin (DM-β-CD), and 2,3,6-tri-O-methyl-β-cyclodextrin 17 
(TM-β-CD) were purchased from Wako (Osaka, Japan), quaternary β-cyclodextrin 18 
(QA-β-CD) and DL-leucine were purchased from Sigma-Aldrich (St. Louis, MO, USA), 19 
and all other reagents were purchased from Nacalai Tesque (Kyoto, Japan). All solutions 20 
were prepared with deionized water purified by using a Direct-Q System (Nihon 21 
Millipore, Japan), and filtered through a 0.45 µm pore membrane filter (Nacalai Tesque) 22 
prior to use. 23 
 24 
 6 
Derivatization of Amino Acids 1 
 Amino acids were derivatized with fluorescein isothiocyanate (FITC) for 2 
laser-induced fluorescence (LIF) detection as in the previous report [24]. Briefly, 5 µL 3 
of 50 mM amino acids and 5 µL of 50 mM FITC dissolved in 50 mM borate buffer (pH 4 
9.5) were mixed and left for 24 h at room temperature. The solution was diluted with 5 
deionized water or a BGS for the appropriate concentrations. 6 
 7 
SPE Purification of Urine Sample 8 
 Urine samples spiked with ibuprofen were purified with a C18 SPE column (Inert 9 
Sep C18, GL science, Kyoto, Japan). Urine was sampled from a healthy male volunteer 10 
and filtered with a 0.45 µm pore membrane filter. Ibuprofen dissolved in methanol (1%, 11 
w/v) was spiked in the urine for certain concentration, followed by adjusting pH to 12 
around 3 by adding 6 M hydrochloric acid. After conditioning the SPE column with 1 13 
mL methanol and 1 mL water, 500 µL of the urine sample was passed through the 14 
cartridge with a gentle gravity pressure at a flow rate of about 0.3 mL/min. The column 15 
was washed with 1.5 mL of water, 0.5 mL of 25 mM formic acid in ACN/water (20/80, 16 
v/v), and 1.5 mL of water again. Ibuprofen was then eluted with 0.5 mL of ACN. The 17 
eluent was lyophilized and the residue was diluted with 500 µL of water for the LVSEP 18 
analysis. 19 
 20 
Capillary Coating 21 
 A fused silica capillary was coated with PVA in the same way as the previous 22 
papers [22,25,26]. Briefly, the capillary was activated and washed with 1 M NaOH and 23 
water, followed by the injection of a 5% PVA solution into the whole capillary. Both the 24 
 7 
capillary ends were immersed in the same PVA solution and left at room temperature for 1 
15 min. The PVA solution was then removed out of the capillary and the capillary was 2 
heated at 140 °C for 18 h under a nitrogen gas flow. The capillary was filled with 3 
deionized water and stored at room temperature. Prior to use, the capillary was flushed 4 
with a BGS for 15 min. 5 
 6 
Apparatus 7 
 All CE experiments were performed on a P/ACE MDQ system (Beckman Coulter, 8 
Fullerton, CA, USA) equipped with a diode-array UV detector or a LIF detector. The 9 
LIF detector used in the LVSEP-CDMEKC analysis consisted of a 488 nm argon ion 10 
laser module and photomultiplier detector with a 520 nm band pass filter. UV detection 11 
was performed at 200 nm in LVSEP-CDCZE or 250 nm in LVSEP-CDEKC. 12 
 13 
Analytical Procedure. 14 
 The capillary with total/effective lengths of 40/30 cm was employed in the 15 
CDCZE analysis and that of 60/50 cm in the CDEKC and CDMEKC analyses. They 16 
were conditioned with deionized water in applying LVSEP or with the BGS in the 17 
conventional CDCZE/CDEKC/CDMEKC analyses at 20 psi for 3 min prior to each run. 18 
Sample injections were performed with a pressure of 20 psi for 90 s (whole capillary 19 
injection) in the LVSEP-applied analyses or 0.3 psi for 3 s in the other conventional 20 
analyses. The applied voltage and the temperature were set at –30 kV and 25 °C, 21 
respectively, except in the CDCZE analysis of ibuprofen with voltage application of –22 




Results and Discussion 2 
Theoretical Consideration 3 
 In LVSEP-CDCZE/CDEKC/CDMEKC, the EOF-suppressed capillary is filled 4 
with a low ionic strength solution containing anionic analytes, whereas the inlet and 5 
outlet vials are filled with the high ionic strength BGS containing CD (Figure 1a). After 6 
applying the voltage, anionic analytes are concentrated at the sample matrix (SM)/BGS 7 
boundary by the difference in the electric field strength between the two zones. The 8 
focused analytes move toward the cathode and the BGS is introduced into the capillary 9 
by the enhanced EOF in the low ionic strength SM (Figure 1b). As the analytes migrate 10 
toward the cathode, the EOF velocity becomes slower and the electric field strength in 11 
the BGS becomes higher (Figure 4-1c). When almost all the SM in the capillary is 12 
removed out from the cathodic capillary end, the electrophoretic velocity of the analytes 13 
exceeds the EOF rate, resulting in the inversion of the sample migration direction 14 
(Figure 4-1d). After the complete removal of the SM, the analytes are separated by 15 
CDCZE/CDECK/CDMEKC during the anodic migration (Figure 4-1e). 16 
 In the LVSEP analysis, the inversion position of the concentrated analytes is 17 
significant for the separation performance [23]. To estimate the effects of the difference 18 
in the separation mode from normal CZE employed in the previous studies, the 19 
inversion position is theoretically considered. In the CDCZE/CDEKC analysis, the 20 































 (1) 22 
 9 
where µep,free, µep,complex, µep,eff,BGS, Kb, [CD], L, V are the electrophoretic mobilities of the 1 
free analyte and the analyte-CD complex, effective electrophoretic mobility of the 2 
analyte in the BGS, binding constant of the analyte with CD, the concentration of CD, 3 
whole capillary length, and applied voltage, respectively. From Eq. (1), we theoretically 4 
calculated the band width (w) and inversion position of the concentrated analyte from 5 
the inlet capillary end (xsc,i) in the same way discussed in the previous paper [23]. The 6 
detailed calculation process is shown in the Supporting Information. The estimated 7 


























































−−=  (when µEOF,SM ≤ –µep,free) (3 – 2) 12 
where µEOF,SM, γ, and e are the electroosmotic mobility in the SM, conductivity ratio 13 
between the SM and the BGS, and base of the natural logarithm, respectively. It should 14 
be noted that all the estimated values are changed from those previously reported by the 15 
factor of µep,eff,BGS/µep,free. In the case of CDMEKC with more complicated interactions 16 
between the micelle, CD, and analytes, the same consideration can also be carried out 17 
because not the complicated interactions but only the obtained value of µep,eff,BGS is 18 
important in our calculation. 19 
 In terms of w, it becomes narrower if the ratio µep,eff,BGS/µep,free is smaller than unity, 20 
 10 
which means that the analytes are more sharply focused. To our knowledge, however, w 1 
mainly depends on the molecular diffusion in the separation step [23], so that the effect 2 
of µep,eff,BGS/µep,free will be limited.  3 
 In terms of xsc,i, the theoretical calculation was carried out on the basis of Eq. 4 
(3–1). In LVSEP using a PVA-coated capillary, typical µEOF,SM of 5.0 × 10–4 cm2v–1s–1 is 5 
usually larger than µep,free of most anionic analytes so that Eq. (3–1) should be applied. 6 
The calculation was performed in the case of the typical LVSEP conditions, µep,free = 7 
–1.0 × 10–4 cm2V–1s–1 and µEOF,SM = 5.0 × 10–4 cm2V–1s–1. The estimated inversion 8 
positions of the concentrated analytes from the anodic capillary end are summarized in 9 
Table 1. The inversion position shifts toward the cathode if the ratio µep,eff,BGS/µep,free is 10 
smaller than unity, which means that longer part of the capillary can be used for the 11 
effective separation. In the chiral analysis of anionic analytes, CDCZE with neutral 12 
chiral selectors or CDEKC with cationic chiral selectors are often employed, because 13 
the reduction in the electrophoretic mobility extends the separation window. Hence, 14 
µep,eff,BGS/µep,free is often smaller than unity, where more efficient sample concentration 15 
and separation with more than 99% effective separation length are expected as shown in 16 
Table 1. In CDMEKC, on the other hand, the analytes interact with the fast migrating 17 
surfactant so that µep,eff,BGS/µep,free tends to be more than unity. In this case, the inversion 18 
position moves toward the anode especially with small γ, causing less effective 19 
separation. As shown in Table 1, however, the effective separation length was estimated 20 
to be more than 93.74% indicating the loss of separation length will not be so 21 
significant. In general, loss of effective separation length would be more minimized by 22 
reducing the salt concentration of the SM and by making the conductivity of the BGS 23 
high to provide enough large γ. 24 
 11 
 1 
LVSEP-CDCZE of Warfarin 2 
 The most fundamental enantioseparation mode, CDCZE using neutral CD was 3 
coupled with LVSEP. To compare the separation performance with that of the 4 
conventional analysis, the same experimental conditions were employed such as the 5 
capillary length, applied voltage, and BGS composition, except for the sample 6 
concentration and sample matrix. The same strategy was also applied to the CDEKC 7 
and CDMEKC analyses in this study. 8 
 In the CDCZE analysis, warfarin was analyzed as a model analyte employing 10 9 
mM DM-β-CD as a neutral chiral selector in 25 mM MES buffer (pH 6.0), in 10 
accordance with the previous paper [28,29]. In the conventional CDCZE analysis, 50 11 
ppm warfarin was well optically separated (Figure 2a) with the resolution of 2.5 (Table 12 
2). In the LVSEP-CDCZE analysis, on the other hand, even 100 ppb racemic warfarin 13 
could be detected with the resolution of 2.6 (Figure 2b), where the sensitivity 14 
enhancement factor (SEF) was estimated to be 1,000. Since the noise level in 15 
LVSEP-CDCZE was similar to that in conventional CDCZE, the SEF was simply 16 










×=   (4) 18 
where, h and C are the peak height and sample concentration, respectively. The relative 19 
standard deviations (RSDs, n = 3) of the detection time, peak height, and peak area in 20 
LVSEP-CDCZE were estimated as 2.0%, 2.1%, and 5.8%, respectively, whereas those 21 
in the conventional CDCZE were 1.6%, 12%, and 17%, respectively.  22 
 In the CDCZE analyses, the anionic analytes form complexes with the neutral CD. 23 
Since the number of total negative charges is not changed in the complex formation but 24 
 12 
the size is increased compared with the free analytes, the charge to size ratio of the 1 
complex is decreased, causing the reduction in the electrophoretic mobility. In the 2 
LVSEP-CDCZE analysis of warfarin, µep,eff,BGS/µep,free was theoretically evaluated as 3 
0.76 and 0.81 for first- and second migrating enantiomer, respectively, at γ = 500 . The 4 
maintained effective separation length was theoretically calculated to be more than 5 
99.8% (see Supporting Information). As with the previous report [22], the effective 6 
separation length in LVSEP-CDCZE was experimentally estimated by subtracting the 7 
migration time (tM) with the time of the drastic current change (ti). As shown in Figure 2, 8 
tM in conventional CDCZE was 15.5 min, whereas (tM – ti) in LVSEP-CDCZE was 15.7 9 
min. These almost identical separation times gave the comparable resolutions, 2.5 and 10 
2.6 obtained with Figure 2a and 2b, respectively. The effective separation length of 11 
101% of the inlet-to-detector length estimated from (tM,LVSEP – ti)/tM,CDCZE agreed well 12 
with the theoretically calculated length of 99.8%. 13 
 14 
LVSEP-CDEKC of Abscisic Acid 15 
 CDEKC using a charged CD was combined with LVSEP for analyzing a plant 16 
hormone, abscisic acid, as a model analyte. We employed 1.5 mM quaternary-β-CD as a 17 
charged chiral selector dissolved in 20 mM MES buffer (pH 6.0), as shown in the 18 
previous paper [29]. In the conventional CDEKC analysis, 250 ppm racemic abscisic 19 
acid was well separated (Figure 3a) with the resolution of 5.0 (Table 2). In the 20 
LVSEP-CDEKC analysis, even 100 ppb racemic abscisic acid could be detected with 21 
the resolution of 4.5 (Figure 3b), where the SEF was estimated as 800. The RSDs (n = 22 
3) of the detection time, peak height, and peak area in LVSEP-CDEKC were estimated 23 
as 1.3%, 4.4%, and 4.6%, respectively, whereas those in the conventional CDCZE were 24 
 13 
0.1%, 4.0%, and 3.5%, respectively.  1 
 The difference in the detection times of conventional CDEKC and 2 
LVSEP-CDEKC was found to be larger than that in CDCZE, which was mainly caused 3 
by the slow matrix removal. In CDEKC, we employed the longer capillary with the 4 
total/effective lengths of 60/50 cm than that of CDCZE with the lengths of 40/30 cm, 5 
but the applied voltage of –30 kV was the same in both cases. From the EOF rate in 6 
LVSEP-CDCZE, the time required for the matrix removal in LVSEP-CDEKC was 7 
calculated to be 5.5 min. However, the actual time (ti) of 7.5 min was longer than that 8 
expected, indicating the reduction in the negative zeta potential of the inner capillary 9 
surface, where QA-β-CD might be adsorbed. Since the zeta potential of the PVA-coated 10 
capillary is fundamentally quite small, even a slight change in the surface condition 11 
tends to cause the drastic change in the enhanced EOF rate. 12 
 In the CDEKC analyses, the anionic analytes form complexes with the cationic 13 
CD, where the number of total negative charges is reduced in the complex formation 14 
and the size is increased compared with the free analytes. Hence the decrease in the 15 
charge to size ratio of the complex causes the reduction in the electrophoretic mobility 16 
as in CDCZE. The ratios of µep,eff,BGS/µep,free (0.56 and 0.59) are smaller than unity, 17 
supporting that the separation ability was maintained in the LVSEP-CDEKC analysis. 18 
 19 
LVSEP-CDMEKC of FITC-labeled Amino Acids 20 
 Amino acids are very important analytical targets in biological analysis, because 21 
they are related with many biological functions such as the protein metabolism, glucose 22 
metabolism, and neural transmission. Recently, the importance of D-amino acids has 23 
been recognized since they are found to be increased or decreased in a human body 24 
 14 
suffering from several diseases in brain, kidney, and liver [2]. Hence, the chiral analysis 1 
of small amount of amino acids with high sensitivity and high resolution is required. 2 
Here, the combination of the LVSEP concentration, high resolution of the CDMEKC 3 
separation, and the high sensitive LIF detection was investigated to achieve the high 4 
performance chiral analyses. 5 
 CDMEKC employing SDS and neutral CD were combined with LVSEP. In the 6 
CDMEKC analysis, arginine (Arg), methionine (Met), and leucine (Leu) derivatized 7 
with FITC were analyzed as model analytes by employing 30 mM SDS and 10 mM 8 
γ-CD as the chiral selector in 40 mM borate buffer (pH 9.5), in accordance with the 9 
previous paper [24]. In the conventional CDMEKC analysis, 100 nM amino acids were 10 
optically resolved (Figure 4a). The resolutions were estimated as 5.1, 5.7, and 6.0 for 11 
Arg, Met, and Leu, respectively (Table 2). In the LVSEP-CDMEKC analysis, even 100 12 
pM amino acids could be detected with the resolution of 4.2, 5.5, and 6.0 for Arg, Met, 13 
and Leu, respectively (Figure 4b). The SEFs were estimated as 1000, 1100, and 1300 14 
for Arg, Met, and Leu, respectively. Opposite to LVSEP-CDEKC, ti of 2.9 min was 15 
much smaller than that expected from LVSEP-CDCZE, probably because the slight 16 
adsorption of anionic SDS increased the negative zeta potential of the inner surface of 17 
the capillary. 18 
 Since the electrophoretic mobility of the FITC-labeled amino acids are increased 19 
by the interaction with the SDS micelle, the ratio µep,eff,BGS/µep,free is larger than unity 20 
especially for earlier detected analytes, which might cause the slight band broadening 21 
and the reduction in the peak-to-peak distance. Typical reduction in resolution for the 22 
first detected Arg with the largest µep,eff,BGS supported our theoretical consideration. 23 
Anyway, the optical resolutions were almost kept up as that in LVSEP-CDCZE/CDEKC, 24 
 15 
indicating the effect of µep,eff,BGS on the preconcentration is often limited. These good 1 
results demonstrated the versatile applicability of LVSEP to many separation modes.  2 
 It should be emphasized again in LVSEP-CDCZE/CDEKC/CDMEKC that the 3 
sample filled in the whole capillary, which is theoretically the maximum injection 4 
volume by pressure, could be well concentrated and separated without much loss of the 5 
effective separation length. Thus, it is not necessary to optimize the sample injection 6 
volume in the LVSEP analysis. This is one of the most invaluable advantages of LVSEP 7 
coupled with any separation modes in CE. 8 
 9 
EE Assay of Ibuprofen 10 
 Quantification of a minor enantiomer from the excessive amount of the major 11 
enantiomer is one of the most important issues in the chiral analysis. However, the large 12 
peak of the excess amount of the enantiomer often overlaps the other peak, making the 13 
quantitative EE assay difficult. If the conventional online concentration techniques were 14 
applied to the EE assay, the reduction in optical resolution would make the chiral 15 
separation more difficult, resulting in poor EE quantification. On the other hand, one of 16 
the most significant advantages of LVSEP is the capability of maintaining the separation 17 
performance, so that the comparable enantioseparation and quantification with a 18 
conventional mode is expected to be provided. Hence, the EE assay was performed to 19 
verify the compatibility of LVSEP with the chiral analysis. 20 
 As a typical assay of 99% EE, the mixture of 99.5% (S)-ibuprofen with 0.5% 21 
(R)-ibuprofen was analyzed both by conventional CDCZE and by LVSEP-CDCZE 22 
using TM-β-CD as a chiral selector [30]. In LVSEP-CDCZE, 2 ppm (S)-ibuprofen and 23 
10 ppb (R)-ibuprofen were well separated with the resolution of 4.7 (Figure 5b), 24 
 16 
whereas 1000 ppm (S)-ibuprofen and 5 ppb (R)-ibuprofen were resolved with the 1 
resolution of 4.8 (Figure 5a). The SEF was evaluated as 500 for both enantiomers, and 2 
the limits of detection (LODs) (S/N = 3) in LVSEP-CDCZE were estimated to be 3.7 3 
ppb and 4.7 ppb for (R)- and (S) ibuprofen, respectively. For quantitative analysis of 4 
enantiomers, the peak areas must be corrected with the factor of vs [31], which is the 5 
sample velocity at the detection point. In the conventional CDCZE analysis, the 6 
electrophoretic mobility is proportional to 1/tM, where tM is the detection time of the 7 
analyte, so that the area can easily be corrected with the factor of 1/tM. In 8 
LVSEP-CDCZE, on the other hand, 1/tM is not proportional to vs because tM includes the 9 
time of the LVSEP concentration process. Since the time of the LVSEP concentration 10 
can be estimated from ti [22], tM was corrected by subtracting with ti in this study for the 11 
EE quantification. As a result, EE was estimated as 99.05% ± 0.048% (n = 4) in 12 
LVSEP-CDCZE and 99.11% ± 0.082% (n = 4) in conventional CDCZE, indicating that 13 
good chiral quantification performance of CDCZE was maintained even after applying 14 
LVSEP. Moreover, the author also succeeded in the assays of the EE ratio up to 99.60%, 15 
where 5 ppm (S)-ibuprofen and 10 ppb (R)-ibuprofen were analyzed by 16 
LVSEP-CDCZE. In conventional CDCZE, on the other hand, such higher EE ratio 17 
could not be determined because the required concentration of (S)-ibuprofen, 2,500 ppm, 18 
was too high to be dissolved in the BGS. Hence, LVSEP-CDCZE is also suitable for the 19 
assay of the high EE ratio. 20 
 21 
Analysis of Ibuprofen in Urine Sample 22 
 Some of the most important targets of the chiral analysis are drug components in 23 
biological fluids such as blood, saliva, and urine. Since these fluids contain many salts 24 
 17 
which directly interfere with the LVSEP preconcentration process, purification such as 1 
gel filtration [22], liquid phase microextraction (LPME) [32], and SPE [33] are required 2 
in the LVSEP-CDCZE analysis. Taking into account of the molecular size of the 3 
analytes, LPME and SPE are suitable in this study. In LPME-LVSEP, however, the EOF 4 
velocity would become too slow in the preconcentration stage due to the combination of 5 
the PVA-coated capillary and a hydrophobic solvent. Thus, SPE-LVSEP with a C18 6 
column was employed in this study. The conductivity of the reconstituted sample 7 
solution was reduced to 10 µS/cm from 20 mS/cm in the original urine sample. As 8 
shown in the previous report [22], the LVSEP analysis could be performed without 9 
dilution when the conductivity of the sample solution is less than 100 µS/cm. Hence, the 10 
desalting performance of the SPE is sufficient for the LVSEP concentration. 11 
 Urine sample containing 500 ppb racemic ibuprofen after the SPE purification was 12 
analyzed in the same LVSEP conditions as discussed in the previous section on the EE 13 
assay. As a typical result, racemic ibuprofen was well detected and optically separated 14 
with the resolution of 5.1 as shown in Figure 6a. By the calibration curve determined 15 
from the analysis of ibuprofen spiked in the blank urine sample with the SPE 16 
purification, the recovery rate was estimated as 84.0% for (S)-ibuprofen and 86.6% for 17 
(R)-ibuprofen. The similar results were obtained in the sample concentration ranging 18 
from 25 ppb to 4.0 ppm, where the limits of quantification (LOQs) (S/N = 10) were 19 
estimated as 14 ppb and 17 ppb for (R)- and (S)-ibuprofen, respectively. Compared with 20 
the LOQs of 500 ppb and 250 ppb in previous reports using SPE-CDCZE [34] and 21 
SPE-HPLC [35], respectively, the better sensitivity in this study indicated the practical 22 
utility of SPE-LVSEP-CDCZE. Thus, sufficient desalting was achieved for the 23 
successful analysis of urine sample by LVSEP-CDCZE. Further improvement of the 24 
 18 
analytical performance for several important analytes with more optimized recovery is 1 
expected to be realized soon by the combination of LVSEP with the SPE 2 




 The effects of the chiral selectors on the LVSEP performance were investigated 7 
both theoretically and experimentally. We demonstrated that the excellent 8 
preconcentration efficiency up to 1,300-fold sensitivity increases was achieved with 9 
maintaining similar optical resolutions. The EE assay of up to 99.6% was also carried 10 
out without loss of analytical performance by LVSEP-CDCZE. Finally, the combination 11 
of the sample purification by using the C18 SPE column with LVSEP-CDCZE was 12 
shown to be useful for the analyses of the real sample containing many unnecessary 13 
salts. Therefore, the application of the easy operating and high performance LVSEP to 14 
the chiral analysis will contribute in many areas such as biology, chemistry, medicine, 15 
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Figure Legends 1 
Figure 1. Concept of LVSEP-CDCZE/CDEKC/CDMEKC in the PVA-coated capillary. 2 
vep, vEOF and vs mean the electrophoretic velocity of the analyte, the EOF velocity, and 3 
apparent velocity of the analyte, respectively. 4 
 5 
Figure 2. Electropherograms of warfarin obtained in (a) conventional CDCZE and (b) 6 
LVSEP-CDCZE. Sample concentration, (a) 50 ppm and (b) 100 ppb; UV detection, 200 7 
nm. The broken line represents the current change in LVSEP-CDCZE. 8 
 9 
Figure 3. Enantioseparations of racemic abscisic acid by (a) conventional CDEKC and 10 
(b) LVSEP-CDEKC. Sample concentration, (a) 250 ppm and (b) 100 ppb; UV detection, 11 
250 nm. 12 
 13 
Figure 4. Enantioseparations of FITC-labeled amino acids in (a) conventional 14 
CDMEKC and (b) LVSEP-CDMEKC. Sample concentration, (a) 100 nM and (b) 100 15 
pM; LIF detection, λex/λem of 488/520 nm. 16 
 17 
Figure 5. EE assay of ibuprofen in (a) conventional CDCZE and (b) LVSEP-CDCZE. 18 
Sample concentration, (a) 1000 ppm (S)-ibuprofen and 5 ppm (R)-ibuprofen; (b) 2 ppm 19 
(S)-ibuprofen and 10 ppb (R)-ibuprofen. UV detection, 200 nm. 20 
 21 
 22 
Figure 6. LVSEP-CDCZE of purified ibuprofen from the urine sample. The original 1 
concentrations of ibuprofen in the urine, (a) 500 ppb and (b) 0 ppb (blank); UV 2 
detection, 200 nm.3 
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Figure 1. Concept of LVSEP-CDCZE/CDEKC/CDMEKC in the PVA-coated capillary. 1 
vep, vEOF and vs mean the electrophoretic velocity of the analyte, the EOF velocity, and 2 
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Figure 2. Electropherograms of warfarin obtained in (a) conventional CDCZE and (b) 1 
LVSEP-CDCZE. Sample concentration, (a) 50 ppm and (b) 100 ppb; UV detection, 200 2 
nm. The broken line represents the current change in LVSEP-CDCZE. 3 
(a) conventional CDCZE 


















tM = 15.5 min 




























tM – ti = 15.7 min 
 25 
 Figure 3. Enantioseparation of racemic abscisic acid by (a) conventional CDEKC and 1 
(b) LVSEP-CDEKC. Sample concentration, (a) 250 ppm and (b) 100 ppb; UV detection, 2 
250 nm.3 
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Figure 4. Enantioseparation of FITC-labeled amino acids in (a) conventional CDMEKC 1 
and (b) LVSEP-CDMEKC. Sample concentration, (a) 100 nM and (b) 100 pM; LIF 2 
detection, λex/λem of 488/520 nm. 3 
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Figure 5. EE assay of ibuprofen in (a) conventional CDCZE and (b) LVSEP-CDCZE. 1 
Sample concentration, (a) 1000 ppm (S)-ibuprofen and 5 ppm (R)-ibuprofen; (b) 2 ppm 2 
(S)-ibuprofen and 10 ppb (R)-ibuprofen. UV detection, 200 nm. 3 
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Figure 6. LVSEP-CDCZE of purified ibuprofen from the urine sample. The original 1 
concentrations of ibuprofen in the urine, (a) 500 ppb and (b) 0 ppb (blank); UV 2 
detection, 200 nm. 3 
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Table 1. Theoretical estimation of the inversion position of the concentrated analytes 1 
from the anodic capillary end.  2 
γ 
µep,eff,BGS/µep,free 
50 100 200 500 1,000 
0.25 99.61 99.77 99.87 99.94 99.97 
0.5 99.22 99.54 99.74 99.88 99.93 
1 98.44 99.08 99.47 99.75 99.86 
2 96.87 98.16 98.94 99.50 99.72 
4 93.74 96.32 97.88 99.01 99.45 
Calculation condition, µep,free = –1.0 × 10–4 cm2V–1s–1 and µEOF,SM = 5.0 × 10–4 cm2V–1s–1. 
Expressed as %ratio of the whole capillary length. 
 3 
Table 2. Summary of the separation mode, employed BGS composition, obtained 4 
resolution, and SEF for each analyte. 5 
analyte separation 
mode BGS composition 
σBGS / 
mS/cm 
Rs (normal / 
LVSEP) SEF 
warfarin CDCZE 10 mM DM-β-CD, 25 mM MES buffer (pH 6.0) 0.54 2.5 / 2.6 1,000 
ibuprofen CDCZE 40 mM TM-β-CD, 25 mM MES buffer (pH 6.0) 0.54 6.7 / 6.9 500 
abscisic 
acid CDEKC 
1.5 mM quaternary-β-CD, 
20 mM MES buffer (pH 6.0) 1.43 5.0 / 4.5 800 
FITC-Arg 5.1 / 4.2 1,000 
FITC-Met 5.7 / 5.5 1,100 
FITC-Leu 
CDMEKC 30 mM SDS, 10 mM γ-CD, 40 mM borate buffer (pH 9.5) 2.70 
6.0 / 6.0 1,300 
 6 
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Highly Sensitive Chiral Analysis in Capillary Electrophoresis 7 
with Large-volume Sample Stacking with an Electroosmotic 8 
Flow Pump 9 
 10 
 11 
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Calculation of the inversion position of the concentrated analytes 1 
 In the main text, detailed calculations from Eq. (1) to Eqs. (2) and (3) are skipped 2 
to be easily understandable. In this supporting section, the complicated calculations are 3 
proposed to obtain w and xsc,i. Although the main stream of the calculation process is 4 
almost the same as that in our previous report, the effect of adding CD into the 5 
electrolyte was discussed in detail. 6 
 7 
 At first, we defined many parameters, xb, xsa, xsc, EBGS, ESM, and so on as shown in 8 
Figure S1. The electroosmotic mobility in the PVA-coated capillary filled with the BGS 9 
(µEOF,BGS) was less than 0.3 × 10–4 cm2V–1s–1, so that µEOF,BGS was neglected in this 10 
study. As discussed in the previous report [18], fundamental parameters are calculated 11 





































 (S4) 16 
 The SM/BGS boundary moves according to the EOF, xb can be expressed as a 17 

































































































 (S5) 1 
If xsa is the position of the anode-side end of the concentrated sample band as shown in 2 
Figure S1, (xsa–xb) is the length by which the analytes at the anode-side end migrate 3 
electrophoretically from the boundary. Therefore, (xsa–xb) can also be calculated by 4 
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 (S11) 13 
From initial condition, xb is equal to L when t = 0. Thus, Eq. (S11) is solved as 14 























 (S12) 15 
By substituting Eq. (S12) into Eq. (S7), the term (xsa–xb) can be expressed as a function 16 

















 (S13) 1 
Provided that xb is xb,B when vep,free,SM exceeds vEOF, and that xb is xb,F when the whole 2 
analytes are stacked out, xb,F can be given as follows. 3 
i) If µEOF,SM > µep,free, some of the analytes were flashed out from the cathodic end due to 4 
the fast EOF. After decreasing the length of the SM zone and increasing the electric 5 
field, the analyte can move against the EOF toward the anode. Hence, this balanced 6 
condition can be expressed as follows, 7 

























=  (S16–1) 10 
Meanwhile, if vep,free,SM > vEOF, the analyte at the cathodic end moves by the length of 11 



















































































 (S17) 13 

























x −==  (S19–1) 1 
ii) If µEOF,SM ≤ µep,free, the analyte can migrate against the fast EOF immediately after the 2 
applying the voltage. Thus, xb,B is equal to L. 3 
 Lx =B,b  (S16–2) 4 






































































































Lex =  (S19–2) 8 
Provided that (xsa,F–xb,F) is w, substitution of Eq. (S19) into (S13) gives w by the 9 
following equation. 10 
















w  (S20–1) 11 






  (S20–2) 12 
When the whole analytes are stacked out, the cathodic side of the concentrated band is 13 
just on the boundary. Therefore, w can be identified as the width of the concentrated 14 
 S6 
band.  1 
 When the concentrated analytes start to move against the EOF, the SM plug length 2 


























=  (S22) 5 
The distance between the cathodic end of the stacked analytes and the cathodic end of 6 
the channel/capillary (xsc) is equal to (xsa – w). From Eqs. (S13), (S20) and (S22), xsc at 7 
the inversion time (xsc,i) is given as follows. 8 




















































 (S23–1) 10 
























































  (S23–2) 12 
Therefore, the effective separation length (xd – xsc,i) is estimated as follows: 13 









xxx +=−   (S24–1) 15 
























−+=−   (S24–2) 1 
 2 
 3 
Fig. S1. Schematic representation for the parameters used in the theoretical model. E 4 
and x mean electric field and the position from the cathodic capillary end. All positions 5 
are expressed as the distance from the cathodic channel end. Subscripts b, sc, sa, and d 6 
mean anodic side of the SM/BGS boundary, cathodic side of the concentrated analyte 7 
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